Douglas Hunt, B.Sc (Hons)

Douglas Hunt, B.Sc (Hons)

Chief Regulatory Affairs, Medical Affairs, and Pharmacovigilance OfficeratPuma Biotechnology· In proxies 2021–2025

Pay in FY2025-13% from the year before · Puma Biotechnology stock +95.1% the same year

Douglas Hunt, B.Sc (Hons) was paid $1.1M in FY2025 (Dec), down 13%. Puma Biotechnology stock rose 95.1% that year.

Pay$100 in the stock at the end of FY20 → $58
Pay is from the Summary Compensation Table of each Puma Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Puma BiotechnologyPublic company · 5 yr
    • Chief Regulatory Affairs, Medical Affairs, and Pharmacovigilance Officer2021 – Present · 5 yrStock in role -7%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?